Stefan Steurer

8.0k total citations
75 papers, 1.7k citations indexed

About

Stefan Steurer is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Stefan Steurer has authored 75 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 33 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Stefan Steurer's work include Prostate Cancer Treatment and Research (20 papers), Cancer Genomics and Diagnostics (8 papers) and Cell Adhesion Molecules Research (7 papers). Stefan Steurer is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Cancer Genomics and Diagnostics (8 papers) and Cell Adhesion Molecules Research (7 papers). Stefan Steurer collaborates with scholars based in Germany, Switzerland and Austria. Stefan Steurer's co-authors include Ronald Simon, Guido Sauter, Sarah Minner, Thorsten Schlomm, Bernd R. Binder, Johannes M. Breuss, Waldemar Wilczak, Gerald W. Prager, Judit Mihaly and Claudia Hube‐Magg and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Stefan Steurer

71 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Steurer Germany 22 697 464 411 392 234 75 1.7k
Nicky D’Haene Belgium 24 610 0.9× 411 0.9× 408 1.0× 597 1.5× 172 0.7× 95 2.0k
Paul Cheng United States 24 1.1k 1.6× 205 0.4× 338 0.8× 336 0.9× 184 0.8× 80 2.2k
Raphaël Saffroy France 27 559 0.8× 343 0.7× 288 0.7× 491 1.3× 74 0.3× 79 1.8k
Thomas Hundsberger Switzerland 20 346 0.5× 364 0.8× 194 0.5× 225 0.6× 399 1.7× 80 1.7k
Bin Fu China 27 842 1.2× 510 1.1× 449 1.1× 237 0.6× 92 0.4× 173 2.1k
Shaolei Lu United States 22 582 0.8× 169 0.4× 274 0.7× 474 1.2× 137 0.6× 81 1.4k
Robert Stöhr Germany 26 1.2k 1.7× 438 0.9× 789 1.9× 538 1.4× 161 0.7× 97 2.7k
Qiuxia Xiong China 10 1.7k 2.4× 204 0.4× 836 2.0× 282 0.7× 262 1.1× 19 2.3k
Darren J. Buonocore United States 16 310 0.4× 568 1.2× 242 0.6× 584 1.5× 61 0.3× 30 1.3k
Joel T. Moncur United States 15 305 0.4× 406 0.9× 339 0.8× 300 0.8× 71 0.3× 43 1.4k

Countries citing papers authored by Stefan Steurer

Since Specialization
Citations

This map shows the geographic impact of Stefan Steurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Steurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Steurer more than expected).

Fields of papers citing papers by Stefan Steurer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Steurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Steurer. The network helps show where Stefan Steurer may publish in the future.

Co-authorship network of co-authors of Stefan Steurer

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Steurer. A scholar is included among the top collaborators of Stefan Steurer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Steurer. Stefan Steurer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delezie, Julien, Pål O. Westermark, Danilo Ritz, et al.. (2024). More than the clock: distinct regulation of muscle function and metabolism by PER2 and RORα. The Journal of Physiology. 602(23). 6373–6402. 4 indexed citations
2.
Viehweger, Florian, Franziska Büscheck, Till S. Clauditz, et al.. (2024). Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors. Biomedicines. 12(5). 957–957. 3 indexed citations
3.
4.
Abdo, Mustafa, Yassine Belloum, David F. Heigener, et al.. (2023). Comparative evaluation of PD‐L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients. Molecular Oncology. 17(5). 737–746. 8 indexed citations
5.
Lennartz, Maximilian, Florian Viehweger, David Dum, et al.. (2023). Abstract 5457: Prevalence of “low” HER2 expression is frequent in breast cancer but also in cancers of other origin: A tissue microarray study on 131 tumor types. Cancer Research. 83(7_Supplement). 5457–5457. 1 indexed citations
6.
Ondruschka, Benjamin, et al.. (2023). Minimally Invasive Tissue Sampling via Post Mortem Ultrasound: A Feasible Tool (Not Only) in Infectious Diseases—A Case Report. Diagnostics. 13(16). 2643–2643. 1 indexed citations
7.
Furrer, Regula, Karl Nordström, Danilo Ritz, et al.. (2023). Molecular control of endurance training adaptation in male mouse skeletal muscle. Nature Metabolism. 5(11). 2020–2035. 36 indexed citations
8.
Furrer, Regula, et al.. (2022). Interleukin‐6 potentiates endurance training adaptation and improves functional capacity in old mice. Journal of Cachexia Sarcopenia and Muscle. 13(2). 1164–1176. 18 indexed citations
9.
Lennartz, Maximilian, Christian Bernreuther, Franziska Büscheck, et al.. (2022). Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16. Urologic Oncology Seminars and Original Investigations. 40(7). 348.e1–348.e8. 1 indexed citations
10.
Schmalfeldt, Barbara, Volkmar Müller, Linn Wölber, et al.. (2021). MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancer. Pathology - Research and Practice. 224. 153533–153533. 3 indexed citations
11.
Fraune, Christoph, Ronald Simon, Claudia Hube‐Magg, et al.. (2020). MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass. Urologic Oncology Seminars and Original Investigations. 38(5). 488–495. 19 indexed citations
12.
Edler, Carolin, Ann Sophie Schröder, Martin Aepfelbacher, et al.. (2020). Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany. International Journal of Legal Medicine. 134(4). 1275–1284. 275 indexed citations
13.
Kempski, Jan, Anastasios D. Giannou, Penelope Pelczar, et al.. (2020). Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival. Cancer Immunology Immunotherapy. 69(6). 1043–1056. 14 indexed citations
14.
Schroeder, Cornelia, Claudia Hube‐Magg, Martina Kluth, et al.. (2019). Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer. BMC Cancer. 19(1). 193–193. 22 indexed citations
15.
Kettunen, Eeva, et al.. (2018). Stromal Caveolin-1 and Caveolin-2 Expression in Primary Tumors and Lymph Node Metastases. Analytical Cellular Pathology. 2018. 1–8. 8 indexed citations
16.
Quaas, Alexander, Martina Kluth, Corinna Wittmer, et al.. (2016). Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients. BMC Cancer. 16(1). 641–641. 19 indexed citations
17.
Burdelski, Christoph, Ronald Simon, Claudia Hube‐Magg, et al.. (2014). Saccharomyces cerevisiae–like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion–positive and fusion-negative cancers. Human Pathology. 46(4). 514–523. 8 indexed citations
18.
Stumm, Laura, Lia Burkhardt, Stefan Steurer, et al.. (2013). Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers. Journal of Clinical Pathology. 66(7). 563–568. 21 indexed citations
19.
Kluth, Martina, Antje Krohn, Stefan Steurer, et al.. (2013). Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions. Modern Pathology. 26(7). 975–983. 80 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicky D’Haene Breakdown of academic impact, for papers by Paul Cheng Breakdown of academic impact, for papers by Raphaël Saffroy Breakdown of academic impact, for papers by Thomas Hundsberger Breakdown of academic impact, for papers by Bin Fu Breakdown of academic impact, for papers by Shaolei Lu Breakdown of academic impact, for papers by Robert Stöhr Breakdown of academic impact, for papers by Qiuxia Xiong Breakdown of academic impact, for papers by Darren J. Buonocore Breakdown of academic impact, for papers by Joel T. Moncur
Rankless by CCL
2026